Featured publications
Atypical Diabetes: What Have We Learned and What Does the Future Hold?
February 8, 2024
Stone SI, Balasubramanyam A, Posey JE. Atypical Diabetes: What Have We Learned and What Does the Future Hold? Diabetes Care. 2024 Feb 8:dci230038. doi: 10.2337/dci23-0038. Epub ahead of print. PMID: 38329838.
Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY)
April 15, 2022
Verma, M., & Stone, S. I. (2022). Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY), Endocrinology, Diabetes & Metabolism Case Reports, 2022, 21-0118.
Digenic Variants in the FGF21 Signaling Pathway Associated with Severe Insulin Resistance and Pseudoacromegaly
September 22, 2020
Stone SI, Wegner DJ, Wambach JA, Cole FS, Urano F, Ornitz DM. Digenic Variants in the FGF21 Signaling Pathway Associated with Severe Insulin Resistance and Pseudoacromegaly. J Endocr Soc. 2020 Dec 1; 4(12):bvaa138. doi: 10.1210/jendso/bvaa138. eCollection 2020 Dec 1. PubMed PMID: 33210059; PubMed Central PMCID: PMC7653638.
Monogenic and syndromic diabetes due to endoplasmic reticulum stress
May 8, 2020
Stone SI, Abreu D, McGill JB, Urano F. Monogenic and syndromic diabetes due to endoplasmic reticulum stress. J Diabetes Complications. 2020 May 8;:107618. doi: 10.1016/j.jdiacomp.2020.107618. [Epub ahead of print] PubMed PMID: 32518033; PubMed Central PMCID: PMC7648725.
Pancreatic stone protein/regenerating protein is a potential biomarker for endoplasmic reticulum stress in beta cells
March 26, 2019
Stone S, Abreu D, Mahadevan J, Asada R, Kries K, Graf R, Marshall BA, Hershey T, Urano F. Pancreatic stone protein/regenerating protein is a potential biomarker for endoplasmic reticulum stress in beta cells. Sci Rep. 2019 Mar 26;9(1):5199. doi: 10.1038/s41598-019-41604-4. PubMed PMID: 30914711; PubMed Central PMCID: PMC6435683.